Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.38 |
| ▸ | GSR | P00390 | 2/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2289857 | 1.00 | PTGS1 (0.41) | PTGS1SLC7A11PMP22SLC1A1SLC1A3 | |
| SCHEMBL28260292 | 0.80 | PMP22 (0.48) | PTGS1SLC7A11PMP22SLC1A1SLC1A3 | |
| SCHEMBL21933072 | 0.78 | PMP22 (0.47) | PMP22SLC1A1SLC1A3SLC1A2GSR | |
| Methane SCHEMBL1237673 | 0.77 | PMP22 (0.46) | PMP22SLC1A1SLC1A3SLC1A2GSR | |
| SCHEMBL8329628 | 0.75 | CA2 (0.33) | — | |
| Cysteine SCHEMBL28050905 | 0.75 | PTGS1 (0.50) | PTGS1SLC7A11PMP22SLC1A1 | |
| SCHEMBL3380958 | 0.75 | GRIK1 (0.39) | PTGS1SLC7A11PMP22SLC1A1SLC1A3 | |
| SCHEMBL6037154 | 0.74 | PGK1 (0.45) | — | |
| SCHEMBL31307678 | 0.74 | NOS3 (0.43) | PTGS1SLC7A11PMP22SLC1A1SLC1A3 | |
| SCHEMBL31307649 | 0.74 | NOS3 (0.43) | PTGS1SLC7A11PMP22SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1489 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101240-A1 | CODON OPTIMIZATION TECHNOLOGY FOR HIGH GENE EXPRESSION AND APPLICATIONS THEREOF | 포항공과대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| EP-3807293-B1 | PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS | ACRAF (IT) | 2026-01-14 | — | — | EP | claimed |
| US-20250332246-A1 | ENHANCED EXPRESSION VIA AUTOTRANSPORTERS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-10-30 | — | — | US | claimed |
| US-20250281535-A1 | ANTI-HUMAN CD45RC BINDING DOMAINS AND USES THEREOF | ABOLERIS PHARMA (FR) | 2025-09-11 | — | — | US | claimed |
| WO-2025136053-A1 | NATRIURETIC PEPTIDE ANALOG AND USES THEREOF | 주식회사 펩트론 | 2025-06-26 | — | — | WO | claimed |
| WO-2025108310-A1 | METHOD FOR PREPARING HETEROLOGOUS MULTIMER BY MEANS OF RECOMBINATION REACTION | 江苏恒瑞医药股份有限公司 | 2025-05-30 | — | — | WO | claimed |
| WO-2025103680-A1 | DETERGENTS AND CLEANING AGENTS COMPRISING LIGNIN DERIVATIVES | HENKEL AG & CO. KGAA (DE) | 2025-05-22 | — | — | WO | claimed |
| US-20250136693-A1 | Anti-PD-1 Antibodies and Fusion Proteins | KADMON CORPORATION, LLC (US) | 2025-05-01 | — | — | US | claimed |
| WO-2025082461-A1 | POLYPEPTIDE, BIOACTIVE CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 优洛生物(上海)有限公司 | 2025-04-24 | — | — | WO | claimed |
| US-12258408-B2 | Oncolytic virus expressing PD-1 binding protein and application of oncolytic virus | SHANGHAI YUANSONG BIOTECHNOLOGY CO. LTD. (CN) | 2025-03-25 | — | — | US | claimed |
| CN-118530315-A | Truncated Zika virus capsid protein or variant thereof | 深圳市第三人民医院(深圳市肝病研究所) | 2024-08-23 | — | — | CN | claimed |
| EP-2752200-B1 | ANTIGEN-BINDING MOLECULE INDUCING IMMUNE RESPONSE TO TARGET ANTIGEN | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2023-11-01 | — | — | EP | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20230159967-A1 | FUNCTIONALISED POLSULPHIDE SYNTHESIS METHOD | ARKEMA FRANCE (FR) | 2023-05-25 | — | — | US | claimed |
| US-20230073411-A1 | HOMODIMER-TYPE BISPECIFIC ANTIBODY AGAINST HER2 AND CD3 AND USE THEREOF | AMPSOURCE BIOPHARMA SHANGHAI INC. (CN) | 2023-03-09 | — | — | US | claimed |
| WO-2023006125-A1 | USE OF SE-DR AFFINITY PEPTIDE IN PREPARING DRUG FOR TREATING RHEUMATIC DISEASE | 河北菲尼斯生物技术有限公司 | 2023-02-02 | — | — | WO | claimed |
| WO-2023277575-A1 | NOVEL CELL-PENETRATING PEPTIDE AND USE THEREOF | 주식회사 아임뉴런 | 2023-01-05 | — | — | WO | claimed |
| WO-2023277628-A1 | NOVEL CELL-PENETRATING PEPTIDE AND USE THEREOF | 주식회사 아임뉴런 | 2023-01-05 | — | — | WO | claimed |
| CN-111187606-B | Surfactant for seawater-based recyclable clean fracturing fluid and preparation method thereof | 江苏海洋大学 | 2022-06-14 | — | — | CN | claimed |
| US-20200149080-A1 | FUNCTIONALISED CYCLIC DITHIOCARBAMATE SYNTHESIS METHOD | ARKEMA FRANCE (FR) | 2020-05-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200149080-A1 | FUNCTIONALISED CYCLIC DITHIOCARBAMATE SYNTHESIS METHOD | TST, DTYMK, DDO | PTGS1 1486/4885SLC7A11 650/4885PMP22 3349/4885 |
| US-20230159967-A1 | FUNCTIONALISED POLSULPHIDE SYNTHESIS METHOD | POLH, POLD1, POLR2H | PTGS1 2456/4885SLC7A11 2768/4885PMP22 2235/4885 |
| US-12258408-B2 | Oncolytic virus expressing PD-1 binding protein and application of oncolytic virus | PDCD1LG2, CD274, PDCD1 | PTGS1 3962/4885SLC7A11 4101/4885PMP22 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.